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To examine the fundamental mechanisms governing neural differentiation, we 
analyzed the transcriptome changes that occur during the differentiation of human 
embryonic stem cells (hESCs) into the neural lineage. Undifferentiated hESCs as 
well as cells at three stages of early neural differentiation, N1 (initiation), N2 (neural 
progenitor cell), and N3 (expressed glial markers) were analyzed using a 
combination of single read, paired-end read, and long read RNA sequencing. The 
results revealed enormous complexity in gene transcription and splicing dynamics 
during neural cell differentiation. We found previously unannotated transcripts and 
spliced isoforms specific for each stage of differentiation. Interestingly, splicing 
isoform diversity is highest in undifferentiated hESCs and decreases upon 
differentiation, a phenomenon we call “isoform specialization.” During neural 
differentiation, we observed differential expression of many types of genes, 
including those involved in key signaling pathways, and a large number of 
extracellular receptors exhibit stage-specific regulation. These results provide a 
valuable resource for studying neural differentiation and reveal new insights into 
the mechanisms underlying in vitro neural differentiation of hESCs, such as neural 
fate specification, NPC identity maintenance and the transition from a 
predominantly neuronal state into one with increased gliogenic potential. 
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INTRODUCTION 
Neural commitment and subsequent differentiation is a complex process. Although the 
complexity of RNAs expressed in neural tissues is very high (1, 2), a comprehensive 
analysis of the genes and RNA isoforms that are expressed during the different stages of 
neural cell differentiation is largely lacking. Such information is expected to be important 
for understanding mechanisms of neural cell differentiation and ultimately providing 
therapeutic solutions for neural degenerative diseases, such as Parkinson's and 
Alzheimer's disease. 
Our current knowledge of the mechanisms involved in neural cell formation is 
derived mostly from studying neurogenesis in the developing embryos of animal models 
(3, 4). However, neurogenesis in animals is a complex process involving many different 
cell types that differentiate asynchronously. This heterogeneity, along with the relatively 
small number of cells that can be readily obtained, makes the analysis of the temporal 
differentiation of individual cell types extremely difficult. One solution is to analyze 
hESCs during in vitro differentiation to different stages of neural development, which can 
be performed using a relatively large numbers of cells (5–9). Analysis of the 
transcriptome in these cells is expected to provide insights into the mechanisms and 
pathways involved in early cell fate specification, such as the acquisition of neurogenic 
potential and the transition to gliogenic potential, which may ultimately be extremely 
useful for pharmacologic screening and neurodegenerative disease therapies.  
Many high-throughput methods have been used previously to study global 
transcription (10–14). The recent development of massively parallel sequencing of short 
reads derived from mRNA (RNA-Seq) makes it possible to globally map transcribed 
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regions and quantitatively analyze RNA isoforms at an unprecedented level of sensitivity 
and accuracy (15–22). Although the use of short reads enables detection of transcribed 
regions and spliced adjacent exons, it has limitations. In particular, the relationship of 
nonadjacent exons and multiple exons within the same transcript cannot be deduced.  
In this study we combined the strengths of several massively parallel sequencing 
technologies, including short Illumina single and paired-end reads (sequence reads from 
both ends of cDNA fragments; 35-bp reads) and longer Roche 454 FLX and Titanium 
sequencing reads (250–450-bp reads) to discern transcript structure and analyze 
transcriptome complexity at an unprecedented level (21, 23, 24). We applied these 
technologies to the analysis of early stages of neural differentiation of hESCs. Our results 
revealed an extraordinary degree of stage-specific transcription and splicing. From more 
than 150 million uniquely mapped sequence reads, we found thousands of unannotated 
transcriptionally active regions (TARs) and unannotated isoforms. Some unannotated 
TARs and splice isoforms are transcribed only at particular stages, implying functional 
roles in specific steps of neural differentiation. Moreover, we describe a phenomenon we 
call isoform specialization, whereby splicing isoform diversity is the highest in 
undifferentiated hESCs and decreases in cells undergoing neural differentiation. Finally, 
the characterization of dynamic changes of gene transcription levels has provided 
important insights into the in vitro neural differentiation of hESCs with regard to neural 
specification, neural progenitor identity maintenance, and the transition from a 
predominantly neuronal nature to one with increased gliogenic potential.  
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RESULTS 
RNA-Seq at specific stages of neural differentiation of hESCs. We characterized 
changes in the transcriptome profiles during early human neural differentiation using H1 
hESC cultures. Two differentiation strategies were used (Fig. 1, Materials and Methods, 
and SI Text). In approach A, the hESC H1 line was differentiated and cultured using 
feeder-free chemically defined adherent cell culture system through three stages: N1, an 
initiation stage; N2, a neural progenitor cell (NPC) stage that produces only neurons upon 
further differentiation; and N3, which produces both neurons and glial cells (Fig. 1 A and 
B) (7, 8, 25). In approach B, neural progenitors (N2-B) were generated from 
undifferentiated H1 hESCs via embryoid body-like neurosphere formation (SI Text) (9). 
In each case, we used standard protocols involving bone morphogenic protein signaling 
antagonists (Noggin) and basic fibroblast growth factor (bFGF) (Materials and Methods). 
 According to qualitative and quantitative analyses, the differentiation protocols 
were highly reproducible. The derived cell populations from each preparation were 
characterized by both immunoassays and FACS analysis for a large variety of markers to 
ensure that the cell cultures were highly homogeneous at the various stages (Fig. 1 and SI 
Text). (i) Undifferentiated hESCs (present in both approaches A and B) expressed all 
hESC surface antigens (e.g., TRA-1-60/81 and SSEA4) as well as transcription factors 
OCT4 and SOX2 (Fig. 1C and SI Text). (ii) N1 initiation stage cells (present only in 
approach A) lost TRA-1-60/81 expression but were still positive for SSEA4, although at 
a lower level, and began to express SSEA1. They also expressed OCT4 at a low level (SI 
Text). (iii) N2 NPCs generated by approach A lost OCT4 as well as SSEA4 expression 
(SI Text) but expressed NESTIN, PAX6, and SOX1 (Fig. 1B). The cells showed a typical 
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morphology of NPCs: bipolar with small soma (Fig. 1A and SI Text). Glial fibrillary 
acidic protein (GFAP) was not expressed (Fig. 1B and SI Text). Upon withdrawal of 
growth factors, the N2 cells predominantly differentiated into neurons rather than glial 
cells, as indicated by the expression of neuronal marker TUJ1 (Fig. 1B). Similarly, >95% 
of N2 neural precursors generated by approach B expressed an array of neural markers 
(neuroepithelial marker PAX6, neural stem cell markers NESTIN, and SOX2, as well as 
neuronal stem/precursor markers MUSASHI) (Fig. 1C and SI Text). The N2 cell 
populations were negative for pluripotent hESC markers such as OCT4 (<0.01%; SI 
Text). (iv) N3 stage cells (only present in approach A) exhibited distinct morphology (Fig. 
1A and SI Text), and GFAP was expressed in these cells (Fig. 1B). After bFGF/EGF 
withdrawal, more glial cells than neurons were generated (Fig. 1B). These events we 
observed in vitro are reminiscent of in vivo neurodevelopment, in which neurogenesis 
occurs before the onset of gliogenesis (25, 26). This phenomenon is also observed in the 
H7 hESC line (SI Text). 
 
Complex gene structure revealed through the integration of short, long, and paired-
end sequences. To characterize the transcription of cells at the specific differentiation 
stages, we generated a combination of 35-bp single reads, 35-bp paired-end reads, and 
250–450-bp long reads. The paired-end reads were from cDNA fragments of different 
lengths, ≈300 bp, 300–600 bp, and 600–1,000 bp. A total of 140, 15, and 1.5 million 
uniquely mapped single, paired-end, and long reads, respectively (summarized in Table 
S1), were generated from two to three biologic replicates from each of the differentiation 
stages (Spearman correlations: 0.94–0.97). The fraction of genes detected at 1-fold 
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average coverage approached saturation for the sequencing of hESC-B and N2-B cells 
(Fig. 2A).   
We achieved extensive sequence depth primarily with the 35-bp single reads; the 
paired-end and 250–450-bp reads provided longer-range exon connectivity information 
and aided in defining complex splice isoforms. Longer reads, particularly 450-bp reads, 
can link up to eight exons (see Fig. 2B for distribution). Fig. 2C illustrates the structure of 
a 16-exon gene that was constructed using a combination of the sequencing technologies. 
 
Identification of unannotated transcribed regions and their connectivity using 
paired-end reads. Consistent with our previous studies (10, 14, 27), thousands of 
unannotated TARs were identified. Specifically, if a TAR overlapped with University of 
California, Santa Cruz (UCSC) gene annotation it was categorized as “known,” and if 
there was no overlap it was classified as “unannotated.” Ninety percent of unannotated 
TARs were validated by RT-PCR from a random sample of 40 TARs identified from the 
different stages (SI Text). We also intersected TARs discovered by our RNA-Seq 
approach with previously published TARs expressed in the liver that were identified by 
tiling microarrays (10). Our study found a large number of hESC RNA that were not 
identified by the tiling microarray study (SI Text), consistent with previous observations 
that RNA-Seq has a higher sensitivity and dynamic range (19). Interestingly, we also 
found that a large number of unannotated TARs (35–65%) were specific for each stage; 
624, 246, 300, and 353 unique unannotated TARs were found for hESC, N1, N2, and N3 
stage cells, respectively (Fig. 3A, Top), raising the possibility that these might have 
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stage-specific functions. Sequences and signal track files can be found in the Gene 
Expression Omnibus (GEO; accession number GSE20301).   
As expected, the majority of the paired-end reads fell within the same known 
exons. However, a small fraction of paired-end reads linked unannotated TARs to either 
UCSC-known annotated genes (0.35%, 0.46%, 1.03%, and 0.58% for hESC, N1, N2, and 
N3, respectively) or to other unannotated TARs (0.36%, 0.38%, 1.50%, and 0.89% for 
hESC, N1, N2, and N3, respectively). Although the percentage of “linking” reads was 
low, their large number allowed for unambiguous connection of TARs, and unannotated 
spliced gene structures could be identified by an overlapping group of paired-end reads. 
Fig. 3B shows an unannotated transcript with at least five exons that was uniquely 
transcribed in hESCs and accurately constructed using a group of overlapping paired-end 
reads. This transcript and expression pattern was validated by RT-PCR (Fig. 3C). Twelve 
such multiexonic unannotated transcripts were further examined using RT-PCR; 11 were 
validated and 6 were verified to be stage specific (Fig. 3C). 
 
Alternative splicing during early neural differentiation of hESCs. In addition to cell 
type–specific gene expression, such as for OCT4 and GFAP, we observed many 
interesting differentiation-stage-specific alternative splicing isoforms. For instance, an 
isoform of neural cell adhesion molecule 1 (NCAM1) was prevalent at the N3 stage, low 
level at the N2 stage, but not detectable at the N1 and hESC stages (Fig. 4A). In addition, 
an isoform of serine/threonine kinase 2 (SLK) was specifically transcribed in hESCs (SI 
Text), consistent with an independent observation by Gage and colleagues (28). Although 
the number of known splice junctions detected in our study was near saturation (Fig. 4B, 
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Top), the number of unannotated splice junctions continued to increase with read depth, 
indicating that there are many more unannotated isoforms yet to be discovered (Fig. 4B, 
Bottom).   
Of particularly high interest is how splice isoform diversity changes as a function 
of cell differentiation, which has not been examined previously. We therefore quantified 
the number of unique splice junctions per composite gene model for each differentiation 
stage (see SI Text for details). To analyze the splice junction diversity, the 500 most 
highly transcribed genes were selected on the basis of the sum of their transcription 
values in the four stages. These abundant transcripts were chosen because they provide 
large numbers of reads and allow for significant splicing differences to be identified. Our 
analysis revealed higher isoform diversity in hESCs compared with the neural stages (the 
median of the junction values for hESC, N1, N2, and N3 are 3.1, 2.2, 1.9, and 2.1, 
respectively). Interestingly, within the chosen set, this observation is independent of 
transcript abundance (Fig. 4C). These data suggest that isoform diversity simplifies 
during differentiation, a process we have named “isoform specialization”.    
 
Distinct classes of genes are differentially transcribed during neural differentiation. 
We next examined the types of genes that exhibited differences in transcription using 
Gene Ontology analysis. We found that genes involved in nervous system development, 
neuron differentiation, brain development, regulation of gene expression, and pattern 
specification were significantly overrepresented among up-regulated genes in N2-B cells 
compared with hESCs (Fig. 5A).   
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Genes were clustered according to the dynamic transcriptome changes between 
the four stages (ES→N1, N1→N2, and N2→N3) (Fig. 5B). We found that a group of 
genes containing SOX1, SOX2, PAX6, MAP2, DCX, ZIC1, NOTCH2, HES1, and 
OLIG2 had the highest transcript levels at the N2 stage and validated the relative 
transcript levels by quantitative PCR (qPCR) (Fig. 5C). H7 hESCs showed similar gene 
expression patterns by qPCR (SI Text). Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathway analysis showed that the neuroactive ligand–receptor interaction 
pathway was enriched among genes that were up-regulated at the N1 and/or N2 stage but 
down-regulated at the N3 stage [these genes are marked by an asterisk (*) in SI Text]. A 
wide variety of receptor genes were transcribed in N1 and N2 cells, suggesting that these 
cells may be capable of differentiating into glutamatergic, GABAergic, dopaminergic, 
cholinergic, adrenergic, and serotoninergic neuronal subtypes. Although the overall 
proliferation rate between N2 and N3 cells in cultures with bFGF/EGF supplement is 
similar, the receptors were diminished at the N3 stage. This is consistent with the fact that 
the N3 stage cells expressed glial markers and had a propensity to differentiate into glial 
cells after bFGF/EGF withdrawal (7).  
 
A coordinated interplay among signaling pathways, such as Wnt and FGF is 
critical for neural specification (3). Components of the Wnt pathway previously 
implicated in noncanonical Wnt signaling [FZD5 (frizzled homolog 5, Drosophila), 
WNT5A, and WNT5B] were found to be down-regulated upon neural differentiation. 
This is consistent with Wnt pathway function in maintaining the undifferentiated state of 
stem cells. Interestingly, a group of FGF family genes exhibited increased expression at 
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the N2 stage and then decreased at the N3 stage. This group included FGF11, FGF13, and 
FGF14, which do not bind to FGF receptor (Fig. 5D); their roles during neural 
differentiation are not well understood.   
 
DISCUSSION 
Our study revealed a high level of transcriptome complexity and dynamics during 
early neural differentiation of hESCs. Alternative splicing has been suggested as a 
driving force for the evolution of higher eukaryotic phenotypic complexity (29), and it 
has been shown recently that ≈94% of human genes undergo alternative splicing (30). 
Previous studies have shown that massively parallel sequencing technology provides the 
ability to monitor spliced isoforms at the level of individual splice junctions (15, 30). Our 
work incorporates the use of paired-end sequencing and demonstrates that this approach 
in conjunction with long reads can elucidate multiple exon connections and thereby 
reconstruct transcribed regions.  
 
Importantly, our study demonstrated that greater splice junction diversity is 
present in hESCs relative to cells undergoing neural differentiation (Fig. 4 B and C). We 
suggest that this high transcript diversity contributes to the pluripotency of hESCs. Upon 
differentiation, more specialized transcripts are used, a process that we call isoform 
specialization. A previous study (31) reported elevated global transcription level in 
murine ESCs compared with NPCs; increased transcription in ESCs would support a 
larger number of isoforms.  
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RNA-Seq also enabled the detection of unknown RNAs (unannotated TARs) (Fig. 
3A). A larger fraction of these unannotated TARs were transcribed in a stage-specific 
fashion compared with the annotated mRNAs (Fig. 3A). It is possible that at least some 
of the unannotated TARs may play an important role in specifying cell differentiation. 
The largest number of unannotated TARs was observed in hESCs, consistent with our 
conclusion that the transcriptome complexity is the greatest in pluripotent hESCs.  
 
One important advantage of massively parallel sequencing is that it is more 
quantitative than other methods (19). RNA-Seq can accurately measure gene 
transcription changes at a genome-wide scale, even for low-abundance transcription 
factors. Thus, these data are a valuable reference data set for researchers studying this 
process.  
 
Our results provide important insights into the hESCs neural differentiation in 
vitro. Specifically, we have revealed aspects of neural specification, neural progenitor 
identity maintenance, and the transition from neurogenesis to gliogenesis. Our data 
suggest the temporal order of transcription of the key transcription factors SOX1 and 
PAX6 during human neural specification. SOX1 is a member of the SOXB1 transcription 
factor family that plays important roles in neuroectodermal lineage commitment and 
maintenance (32, 33). PAX6 is a highly conserved transcription factor essential for 
central nervous system development (34). The temporal order of their transcription and 
their roles in human neuroectodermal specification are not fully understood. In mice 
SOX1 was found to be the earliest transcribed neural marker, preceding PAX6. PAX6 is 
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first transcribed in radial glial cells during the differentiation of mouse ESCs (35), and it 
has been reported to be involved in the progression of neuroectoderm toward radial glia 
(36). However, in our experiments using hESCs, PAX6 mRNAs appeared before SOX1 
mRNA, consistent with the immunostaining observations of Gerrard et al. (7). Thus, 
PAX6 may have an earlier role in neural lineage choice in human ESCs than in mouse 
ESCs.  
 
The transcription of a wide variety of receptor genes at the N1 and N2 stages 
indicates that if the proper differentiation conditions are applied, these cells could 
potentially differentiate into glutamatergic, GABAergic, dopaminergic, cholinergic, 
adrenergic, and serotoninergic neuronal subtypes. Two possibilities can explain why 
these neuroactive ligand–receptors are not retained in N3 cultures. First, the receptors 
may be lost in N3 cells owing to cell death and/or less proliferation of proneuronal cells; 
the proneuronal cells would then be gradually replaced by the proglial cells. However, 
this cannot explain the complete absence of GFAP when neuronal differentiation is 
induced at an earlier stage. The second possibility is that a series of gene repression and 
activation events lead to the transition of the cells from a proneuronal nature to a proglial 
nature. Our finding that FGF family genes, including nonFGF-receptor-binding FGF11, 
FGF13, and FGF14, increase at the N2 stage and decrease at the N3 stage (Fig. 5D) raises 
the possibility that modifying their levels may help to maintain hESC-derived neural cells 
at the neuronal stage.  
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Overall, our approach can serve as a template for the investigation of dynamic 
temporal or spatial transcriptome changes during various developmental processes. 
Future improvements of sequencing technologies, including longer reads, higher 
throughput, and reduced cost will aid in the definition of transcriptomes and alternative 
splicing in specific temporal and spatial contexts. 
 
MATERIALS AND METHODS 
hESC culture and neural differentiation using two approaches 
Approach A: H1 hESCs were cultured in Matrigel-coated plates in mouse embryonic 
fibroblast conditioned medium supplemented with 8 ng/mL bFGF as previously 
described (37). Cells were propagated at a 1:3 ratio by treatment with 200 U/mL 
collagenase IV and mechanical dissection. Neural differentiation was carried out as 
previously described (7). Briefly, hESCs were split with EDTA at 1:5 ratios into culture 
dishes coated with poly-L-lysine/laminin (Sigma-Aldrich) and cultured in N2B27 
medium supplemented with 100 ng/mL mouse recombinant Noggin (R&D Systems). At 
this stage, cells were defined as passage 1 (P1), and N1 cells were collected at Day 11 of 
the differentiation. Cells of P1 and P2 were split by collagenase into small clumps, 
similar to hESC culture, and continuously cultured in N2B27 medium with Noggin. From 
P3, cells were plated at the density of 5 × 104 cells/cm2 after disassociation by TrypLE 
express (Invitrogen) into single-cell suspension, and cultured in N2B27 medium with the 
addition of 20 ng/mL bFGF and EGF. Cells can be maintained under this culture 
condition for a long time with a stable proliferative capacity. N2 cells were collected at 
P9 and N3 at P22. To induce postmitotic cell types, bFGF and EGF were withdrawn, and 
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neural progenitors were continually cultured in N2B27 for 7 days. Cells from the 
different stages were analyzed for homogeneity by flow cytometry analysis. Cells from 
N2 and N3 were stained with anti-SOX1 (Abcam), SOX2 (Abcam), and MUSASHI 
(Chemicon) antibodies; 10–20,000 cells were analyzed (see SI Text for details).   
 
Approach B: All experiments involving hESCs were approved by the Yale Embryonic 
Stem Cell Oversight Committee. hESC line H1 (WA01, WiCell) was maintained in 
undifferentiated state by culturing on Matrigel-coated plates (BD) in feeder-free and 
serum free, component-defined conditions. Briefly, the cells were cultured in 
DMEM/F12 medium (Invitrogen) supplemented with 1% MEM-nonessential amino acids 
(Invitrogen), 1 mM L-glutamine, 1% penicillin-streptomycin, 50 ng/mL bFGF (FGF-2) 
(Millipore), 1× N2 supplements, and 1× B27 supplements (Invitrogen) (38), with daily 
media change. H1 cells were passaged every 4–6 days by dissociation with 1 mg/mL 
collagenase IV (Invitrogen). The hESCs used were between passages 30 and 70 with 
normal karyotype and expressed conventional hESC markers. hESCs were differentiated 
by neural sphere formation with some modifications of previously published protocols 
(9). Cells were fixed and analyzed by standard fluorescent immunocytochemical 
techniques. See SI Text for details. 
 
RNA-sequencing 
Construction of Solexa sequencing Library. mRNA samples were extracted and double-
polyA purified from cell cultures using Oligotex Direct mRNA Kits followed by Oligotex 
mRNA Kits, according to the manufacturer's instructions (Qiagen). mRNA (500 ng) was 
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used in each sequencing library. mRNA was fragmented using 10× Fragmentation Buffer 
(Ambion), and double-stranded cDNA was synthesized using SuperScript II (Invitrogen) 
RT and random primers. DNA sequencing followed the instructions of the mRNA-
Sequencing Sample Prep Kit (Illumina) as previously described (16). 
 
454 sequencing Library preparation. mRNA was prepared as described above. mRNA 
samples (200–500 ng) were heat fragmented. Single-stranded cDNA library was 
synthesized, and adapters were ligated (SI Text) and sequenced using the emPCR II Kit 
(Amplicon A) and on the 454 Genome Sequencer FLX instrument according to the 
manufacturer's instructions. GS FLX Titanium cDNA libraries were prepared and 
sequenced at the 454 Life Sciences Sequencing Centre.   
 
RT-PCR and Real-time quantitative RT-PCR. RT-PCR was carried out as described 
previously (12, 14). RNA without RT treatment was used as negative control. See SI Text 
for primers and details. 
 
Bioinformatic analyses. Please see SI Text. 
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FIGURE LEGENDS: 
Fig. 1. Characterization of neural differentiation cell cultures. (A) Schematic 
representation of the neural differentiation procedure and four stages by approach A: 
hESCs, N1, N2, and N3. (B) Immunofluorescence labeling of genes specifically 
expressed in N2 and N3 cells (H1 hESCs) prepared by approach A with or without 
growth factors. SOX1, NESTIN, and PAX6 are expressed in N2 cells with growth factors 
bFGF/EGF. TUJ1 is expressed in N2 cells without growth factors; GFAP is not 
expressed. GFAP is expressed in N3 cells after growth factor withdrawal, whereas TUJ1 
expression is still visible. Blue: nuclei are stained by DAPI. (C) Immunostaining 
characterization of cell cultures (H1 hESCs) by approach B. SOX2 is expressed in hESCs 
but not NESTIN. Both NESTIN and SOX2 are expressed in N2 cells. Higher-resolution 
photos are in SI Text.  
 
Fig. 2. Overview of transcript characterization by RNA-Seq. (A) Fraction of genes 
detected as a function of read depth. (B) Number of exons spanned by 450-bp reads. (C) 
Transcript complexity revealed by integrating short, long, and pair-end sequence 
information. Only the spliced reads for single-end and long reads are shown. For paired-
end reads the same RNA fragments are shown as two vertical bars connected by a line. 
 
Fig. 3. Stage-specific unannotated TARs and their connectivity by paired-end reads. (A) 
(Upper) The number of unannotated, known, and unique TARs found at each stage. 
TARs that overlap with a UCSC gene are classified as “known.” Those that have no 
overlap with a UCSC gene annotation are called “unannotated.” TARs that do not overlap 
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with TARs in other differentiation stages are called “unique” to that particular stage. 
(Lower) Fractions shared between stages for known TARs and unannotated TARs, 
respectively. (B) The transcript structure of an unannotated transcript (Transcript 1) that 
is uniquely transcribed in hESCs is reconstructed using paired-end reads. (C) RT-PCR 
validation of unannotated transcripts identified by groups of paired-end reads. Transcript 
1 and its RT-PCR primer set are shown in B. Transcripts 1–3 are specifically expressed in 
hESCs, transcript 4 in N1–N3 cells, transcript 5 in ES-N2 cells, and transcript 6 in ES, 
N1, and N3 cells. 
 
Figure 4. Splicing analysis. (A) One of the transcript isoforms of neural cell adhesion 
molecule 1 (NCAM1) (marked by a rectangle and arrow) is primarily expressed in N3 
and very weakly at N2 but not at N1 and hESC stages. The y axis of the RNA-Seq signal 
tracks represents the read density normalized by the number of mapped reads per million 
for each cell type. Two sets of RT-PCR primers were designed on the alternative exon 
and the adjacent constant exon, which generated two products of slightly different sizes. 
The DNA ladder and the RT-PCR products were from the same gel. (B) (Upper) The 
number of known splice junctions detected nears saturation. (Lower) The number of 
unannotated splice junctions does not saturate at this read depth. (C) Splicing diversity is 
the highest in hESCs and decreases when cells commit to neural differentiation. The top 
500 highly expressed genes shown here were clustered by splice junction diversity (k-
means clustering, k = 3) (see SI Text for details). The splice junction diversity value was 
defined as the number of unique splice junctions detected in the composite gene model 
given all of the mapped splice junction reads; thus the junction diversity values were 
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normalized for the number of annotated splice junctions in the composite gene model and 
the number of mapped reads per million. Splice junction diversity is independent of 
transcript abundance for this set of genes. 
 
Fig. 5. Dynamics of gene expression during neural differentiation. (A) The enriched 
Gene Ontology (GO) categories among up-regulated genes (>2-fold) in N2 cells 
compared with hESCs. (B) Quantification of dynamic transcriptome changes during 
neural differentiation process [x axis: differentiation stages hESC, N1, N2, and N3; y 
axis: log2(gene expression values by RNA-Seq)]. Twenty-seven patterns were identified 
from clustering the expression changes of the UCSC gene annotation set. U, up-
regulation; D, down-regulation; F, flat (<2-fold change). (C) qPCR validation of the 
genes that show the highest expression at N2. y axis: log2(relative gene expression level 
for each stage normalized using HPRT). (D) qPCR validation of FGF family gene 
expression (Note: qPCRs were performed for two isoforms of FGF13.) Expression of 
FGF12 and FGF13a was not detected in N3 by qPCR.   
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